NASP data highlight reduction in disease burden among people living with uncontrolled goutGamifant (emapalumab) data showed response rates in ...
Incyte today announced new data from the Phase 3b TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib cream) in adults with moderate atopic dermatitis (AD) who had an ...
On Saturday, Sept. 16, 2023, Sam Terblanche, a junior at Columbia University, went to a soccer match at Yankee Stadium. On ...
Summer McKesson’s quest for answers to her medical condition would unearth a family secret – and a doctor’s decades-old ...